DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes

Publisher： Karger

E-ISSN： 1664-5502|3|1|48-56

ISSN： 1664-3828

Source： Cardiorenal Medicine, Vol.3, Iss.1, 2013-03, pp. : 48-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin Resistance and Skeletal Muscle Vasculature: Significance, Assessment and Therapeutic Modulators

By  

Cardiorenal Medicine, Vol. 4, Iss. 3-4, 2014-12 ,pp. : 244-256

Karger

Access to resources Recommend Favorite

Renal and Cardiac Effects of DPP4 Inhibitors – from Preclinical Development to Clinical Research

By  

Kidney and Blood Pressure Research, Vol. 36, Iss. 1, 2012-08 ,pp. : 65-84

Karger

Access to resources Recommend Favorite

Correlation between the Indexes of Insulin Resistance and Renal Function in the Presence of Hypertension

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 3, 2010-06 ,pp. : 209-212

Karger

Access to resources Recommend Favorite

Obesity and the Cardiorenal Metabolic Syndrome: Therapeutic Modalities and Their Efficacy in Improving Cardiovascular and Renal Risk Factors

By  

Cardiorenal Medicine, Vol. 2, Iss. 4, 2012-11 ,pp. : 314-327

Karger

Access to resources Recommend Favorite

Validation of Simple Indices to Assess Insulin Sensitivity and Pancreatic Beta-Cell Function in Patients with Renal Dysfunction

By  

Nephron, Vol. 92, Iss. 3, 2002-09 ,pp. : 713-715

Karger

Access to resources Recommend Favorite